Naleen Raj Bhandari

12PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
The Waiting Game: How NGS and Guideline-Concordant-Care Timing Shape Survival in Advanced NSCLC.

|Apr 10, 2026
Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study.

Christine Michaels-Igbokwe, Hui Lu, Katherine B Winfree

|Feb 27, 2026
Efficacy of Pirtobrutinib Monotherapy in Treatment-Naïve Chronic Lymphocytic Leukemia: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Toby A Eyre, Lisa M Hess, Ehsan Masoudi

|Dec 07, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Jennifer A Woyach, Lugui Qiu, Sebastian Grosicki

|Aug 14, 2025
Overall Survival Associated with Real-World Treatment Sequences in Patients with CLL/SLL in the United States.

Joanna M Rhodes, Naleen Raj Bhandari, Manoj Khanal

|Mar 23, 2025
Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.

Nitin Jain, Toby A Eyre, Katherine B Winfree

Pageof 2

Frequent Collaborators

5 joint publications

Lisa M Hess

2 joint publications

Nalin Payakachat

1 joint publications

Mahmoud I Khalil

1 joint publications

Austin K Bramwell